BI
The startup provides an AI-driven spatial analysis platform that utilizes machine learning algorithms to identify and characterize cancerous tumors. This technology enhances the pharmaceutical sector's ability to develop targeted therapies by delivering precise biological insights into complex diseases.
Updated 3 months ago
Funding
$580K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup provides an AI-driven spatial analysis platform that utilizes machine learning algorithms to identify and characterize cancerous tumors. This technology enhances the pharmaceutical sector's ability to develop targeted therapies by delivering precise biological insights into complex diseases.